European Urology - Lasers for the Treatment of Bladder Outlet Obstruction: Are They Challenging Conventional Treatment Modalities?
Monday, 11 September 2006
Volume 50, Issue 3, Pages 418-420 (September 2006) Benign prostatic hyperplasia (BPH) is the most common benign neoplasm among aging men and, at the same time, the most frequent male tumor requiring surgical intervention. Transurethral resection of the prostate (TURP) still remains the “reference” instrumental treatment for benign prostatic obstruction, but the significant morbidity related to this surgical procedure has powered the development of various high-energy alternative treatment options.
read more
|
Urologic Nursing News Briefs - Special Issue: Men's Health
Friday, 11 August 2006
Urologic Nursing marks a milestone with the August 2006 issue, its first special issue on men's health.
read more
|
Urologic Professionals to Learn Latest Practice Advances at Society of Urologic Nurses and Associates Annual Conference
Monday, 10 July 2006
Pitman, NJ - The Society of Urologic Nurses and Associates' (SUNA) will hold its 2006 Annual Conference in Kansas City, MO, October 27-30, 2006, at the Hyatt Regency Crown Center.
read more
|
AUA 2006 - Surgical Treatments Of BPH
Wednesday, 24 May 2006
By David Lee, MD, This session focused on the surgical treatments of BPH. One of the very interesting presentations was from Albertson et al (ABST 1425) focusing on practice patterns of urologists certifying or recertifying with the American Board of Urology.
read more
|
AUA 2006 - New Insights Into LUTS/BPH
Wednesday, 24 May 2006
Dr. Claus Roehrborn moderated a panel discussion session on "Case Studies of New Insights into LUTS/BPH" at the Plenary Session of the AUA on Wednesday May 24, 2006.
read more
|
Male Nocturia Can Have Multiple Causes
Monday, 24 April 2006
NEW YORK (Reuters Health) - Even though male nocturia in old age is primarily attributed to bladder outlet obstruction caused by prostatic hyperplasia, several other conditions may be responsible, urologists in Taiwan report.
read more
|
Laser Prostate Treatment Safe In Men Using Anticoagulant Therapy
Monday, 24 April 2006
NEW YORK (Reuters Health) - Holmium laser enucleation of the prostate (HoLEP) is a safe and effective treatment for symptomatic BPH in men receiving anticoagulant therapy, Canadian researchers report.
read more
|
FDA Approves New Urologix Coolwave TM Control Unit
Thursday, 20 April 2006
MINNEAPOLIS ? April 6, 2005 ? Urologix®, Inc. (NASDAQ:ULGX), has received permission, through the approval of
three PMA supplements relating to new hardware and software, from the U.S. Food and Drug Administration to market
its new CoolWave? control unit.
read more
|
Men Have High Prevalence Of Lower Urinary Tract Symptoms
Monday, 10 April 2006
PARIS (Reuters Health) - About 60% of adult men are affected by at least one lower urinary tract symptom (LUTS) and the prevalence increases with age, according to the findings of the EPIC study, which were presented at the 21st Congress of the European Association of Urology.
read more
|
Tolterodine Safely Given To Men With Overactive Bladder And Obstruction
Friday, 24 March 2006
NEW YORK (Reuters Health) - Antimuscarinic therapy with the drug tolterodine is a well-tolerated treatment for overactive bladder in men with bladder outlet obstruction and does not seem to cause urinary retention, according to a report in the Journal of Urology for March.
read more
|
BPH & Male LUTS 
